–
Candel Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
FY22:
–
FY23:
–
FY24:
–
FY25:
0
(positive)
Change from FY21 to FY25
millions USD
FY21:
−25.7
FY22:
−34.7
FY23:
−38.4
FY24:
−33.4
FY25:
−48.3
(positive)
Change from FY23 to FY24
millions USD
FY21:
–
FY22:
–
FY23:
−35.4
FY24:
−31.3
FY25:
–
(positive)
Change from FY23 to FY25
millions USD
FY21:
–
FY22:
–
FY23:
−37.9
FY24:
−55.2
FY25:
−38.2
(positive)
Change from FY21 to FY25
millions USD
FY21:
−36.1
FY22:
−18.8
FY23:
−37.9
FY24:
−55.2
FY25:
−38.2
All amounts in millions USD